Literature DB >> 22547597

Under-representation of older adults in cancer registration trials: known problem, little progress.

Kevin S Scher, Arti Hurria.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22547597     DOI： 10.1200/JCO.2012.41.6727

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  102 in total

1.  Phase 2 study of frontline brentuximab vedotin monotherapy in Hodgkin lymphoma patients aged 60 years and older.

Authors:  Andres Forero-Torres; Beata Holkova; Jerome Goldschmidt; Robert Chen; Gregg Olsen; Ralph V Boccia; Rodolfo E Bordoni; Jonathan W Friedberg; Jeff P Sharman; Maria Corinna Palanca-Wessels; Yinghui Wang; Christopher A Yasenchak
Journal:  Blood       Date:  2015-09-16       Impact factor: 22.113

Review 2.  Immunotherapy in Older Adults with Cancer.

Authors:  Richard Curtis Godby; Douglas B Johnson; Grant R Williams
Journal:  Curr Oncol Rep       Date:  2019-05-07       Impact factor: 5.075

3.  Engaging older patients with cancer and their caregivers as partners in cancer research.

Authors:  Nikesha J Gilmore; Beverly Canin; Mary Whitehead; Margaret Sedenquist; Lorraine Griggs; Lynn Finch; Valerie Grossman; Valerie Targia; Megan Wells; Charles Kamen; Marie Flannery; Allison Magnuson; Sandy Plumb; Spencer Obrecht; Lisa M Lowenstein; Gilberto Lopez; Jainy Anderson; Jeffrey Berenberg; Victor Vogel; James Bearden; William Dale; Supriya G Mohile
Journal:  Cancer       Date:  2019-08-16       Impact factor: 6.860

4.  The efficacy of adjuvant chemotherapy for resected high-risk stage II and stage III colorectal cancer in frail patients.

Authors:  Kosuke Mima; Nobutomo Miyanari; Keisuke Kosumi; Takuya Tajiri; Kosuke Kanemitsu; Toru Takematsu; Mitsuhiro Inoue; Takao Mizumoto; Tatsuo Kubota; Hideo Baba
Journal:  Int J Clin Oncol       Date:  2021-01-28       Impact factor: 3.402

5.  Healthy Living After Cancer Treatment: Considerations for Clinical and Community Practice.

Authors:  Shirley M Bluethmann; Christopher N Sciamanna; Renate M Winkels; Kathleen M Sturgeon; Kathryn H Schmitz
Journal:  Am J Lifestyle Med       Date:  2018-02-07

6.  Treatment, trial participation and survival in adult acute myeloid leukemia: a population-based study in the Netherlands, 1989-2012.

Authors:  A G Dinmohamed; O Visser; Y van Norden; N M A Blijlevens; J J Cornelissen; G A Huls; P C Huijgens; P Sonneveld; A A van de Loosdrecht; G J Ossenkoppele; B Löwenberg; M Jongen-Lavrencic
Journal:  Leukemia       Date:  2015-07-17       Impact factor: 11.528

7.  The Efficacy and Safety of Conventional and Hypofractionated High-Dose Radiation Therapy for Prostate Cancer in an Elderly Population: A Subgroup Analysis of the CHHiP Trial.

Authors:  James M Wilson; David P Dearnaley; Isabel Syndikus; Vincent Khoo; Alison Birtle; David Bloomfield; Ananya Choudhury; John Graham; Catherine Ferguson; Zafar Malik; Julian Money-Kyrle; Joe M O'Sullivan; Miguel Panades; Chris Parker; Yvonne Rimmer; Christopher Scrase; John Staffurth; Andrew Stockdale; Clare Cruickshank; Clare Griffin; Emma Hall
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-01-09       Impact factor: 7.038

8.  Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics.

Authors:  Carol Sweeney; Philip S Bernard; Rachel E Factor; Marilyn L Kwan; Laurel A Habel; Charles P Quesenberry; Kaylynn Shakespear; Erin K Weltzien; Inge J Stijleman; Carole A Davis; Mark T W Ebbert; Adrienne Castillo; Lawrence H Kushi; Bette J Caan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-02-12       Impact factor: 4.254

9.  Geriatric assessment factors are associated with mortality after hospitalization in older adults with cancer.

Authors:  Sushma Jonna; Leslie Chiang; Jingxia Liu; Maria B Carroll; Kellie Flood; Tanya M Wildes
Journal:  Support Care Cancer       Date:  2016-07-27       Impact factor: 3.603

10.  Is the lack of evidence in older adults with cancer compromising safety?

Authors:  Darryl Outlaw; Grant R Williams
Journal:  Expert Opin Drug Saf       Date:  2020-08-05       Impact factor: 4.250
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.